XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 2 - Other Assets
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Other Assets Disclosure [Text Block]
2
Other
Assets
 
The total capitalized costs of the Company’s SAP enterprise resource planning software platform (“ERP Platform”) of
$22.0
million, including capitalized interest, are recorded on the Consolidated Balance Sheet in Other Assets, net of accumulated amortization of
$31.1
million. Amortization expense relating to the ERP Platform, which is recognized in depreciation and amortization expense in the Consolidated Statements of Income and Comprehensive Income, was
$11.1
million for the
three
months ended
March 31, 2018
and
$0.9
million for the
three
months ended
March 31, 2017.
 
In the
first
quarter of
2018,
as part of an assessment that involved a technical feasibility study of the current ERP Platform, the Company determined that a majority of the components of its ERP Platform will require replacement earlier than originally anticipated; in prior disclosures, the Company had referred to the ERP Platform separately as the SAP enterprise software and SAP dealership management system. In accordance with Accounting Standards Codification (“ASC”) Topic
350
-
40,
in the
first
quarter of
2018,
the Company adjusted the useful life of these components expected to be replaced so that the respective net book values of the components are fully amortized upon replacement. The Company expects to replace these components
no
later than
May 2018.
The Company began to amortize the remaining net book value of the components that are expected to be replaced on a straight-line basis in
February 2018
and will continue through
May 2018.
In the
first
quarter of
2018,
the Company recognized an additional
$10.2
million of amortization expense related to the components of the ERP Platform that will be replaced. The ERP Platform asset and related amortization are reflected in the Truck Segment.
 
The Company’s only significant identifiable intangible assets, other than goodwill, are rights under franchise agreements with manufacturers. The fair value of the franchise right is determined at the acquisition date by discounting the projected cash flows specific to each acquisition. The carrying value of the Company’s manufacturer franchise rights was
$7.0
million at
March 31, 2018
and
December 31, 2017,
and is included in Other Assets on the accompanying consolidated balance sheets. The Company has determined that manufacturer franchise rights have an indefinite life, as there are
no
economic or other factors that limit their useful lives and they are expected to generate cash flows indefinitely due to the historically long lives of the manufacturers’ brand names. Furthermore, to the extent that any agreements evidencing manufacturer franchise rights have expiration dates, the Company expects that it will be able to renew those agreements in the ordinary course of business. Accordingly, the Company does
not
amortize manufacturer franchise rights.
 
Due to the fact that manufacturer franchise rights are specific to geographic region, the Company has determined that evaluating and including all locations acquired in the geographic region is the appropriate level for purposes of testing franchise rights for impairment. Management reviews indefinite-lived manufacturer franchise rights for impairment annually during the
fourth
quarter, or more often if events or circumstances indicate that an impairment
may
have occurred. The Company is subject to financial statement risk to the extent that manufacturer franchise rights become impaired due to decreases in the fair market value of its individual franchises.
 
The significant estimates and assumptions used by management in assessing the recoverability of manufacturer franchise rights include estimated future cash flows, present value discount rate and other factors. Any changes in these estimates or assumptions could result in an impairment charge. The estimates of future cash flows, based on reasonable and supportable assumptions and projections, require management’s subjective judgment. Depending on the assumptions and estimates used, the estimated future cash flows projected in the evaluations of manufacturer franchise rights can vary within a range of outcomes.
 
No
impairment write down was required in the period presented. The Company cannot predict the occurrence of certain events that might adversely affect the reported value of manufacturer franchise rights in the future.